PawPro®Longevity for Pets
Command CenterVirtual LabRequest briefing
PawPro GmbH · GermanyU.S. Foundation & HoldingLuxembourg HQ
A healthy golden retriever, illuminated by soft teal light
SCIENCE-LED CARE. A LIFELONG DIFFERENCE.

PawPro®
Longevity for Pets.

Supporting pet health and longevity education.

From an existing product portfolio to a scalable Longevity Ecosystem — through research, AI, education and innovation.

Request briefing Explore the ecosystem

Luxembourg · Our future headquarters for global growth

Grounded in science.Inspired by a life well lived.
DISCOVER THE PAWPRO STORYVENTURE FAIR · OCTOBER 2026
THE DOGS BEHIND THE MISSIONWally and Lou, Katrina Graue’s dogs, pictured in the original PawPro deck
20years of Wally’s life
OUR ORIGIN

A diagnosis.
A determination.
A lifelong mission.

It began with Wally. When he was diagnosed with a serious illness at 14, Katrina Graue worked with scientific partners on supporting his quality of life. That is how PAWPRO Original came about.

After PAWPRO Original, Wally gained significant quality of life and lived another six years — to age 20.

Individual results vary. Wally’s story is not a medical claim.

“We combine business success with social responsibility — for animals, pet owners and animal shelters.”Katrina Graue · Founder & CEO, PawPro
01

The conviction

Scientific innovation can improve pets’ health and quality of life.

02

The portfolio

12 complementary products on the market. 4 more in development.

03

The ecosystem

Supporting health and longevity education through research and AI.

04

The next chapter

Partners and investors to scale an existing business.

VENTURE FAIR · 03 / 20

An existing business. A clear next chapter.

Traction and team, as reported in the October 2026 deck.

12

products on the market

4

in development / testing

2

commercial contracts

6

international LOIs

6 mo.

active in the US market

≈ €1.8m

own investment

YEAR 1 · US ONLY · FINANCIAL PLAN€13.2m

Contractually agreed volume and planned Amazon sales are distinct. Neither is a statement of recognized revenue.

Contractually agreed distributor volume

€3.6m

190,000 units of PAWPRO Original contractually agreed with the US B2B distributor. Called off to date: 5,000 units — not 190,000 delivered units.

Further channels: six international LOIs and the 12-product portfolio.

October 2026 deck · illustrative base case, not a forecast or investment advice. Plans depend on execution; terms are subject to negotiation.

The core team

Katrina Graue

Founder & CEO

International business development & digital transformation

Kai Erdel

CFO

Finance, strategy & governance

Matthias Diekmann

IT, AI & Data

IT systems, artificial intelligence & data

Aureliano J. Recktenwald

Cybersecurity & Compliance

Cybersecurity & compliance

Maximillian Nelles

Project & PMO Manager

Project management & PMO

THE LONGEVITY ECOSYSTEM

More than products.
A connected future for pet health.

Science, data, AI, direct manufacturing and societal impact. Five building blocks, one shared purpose.

PawPro products are complementary feed, not a substitute for veterinary care. Consult your veterinarian about your pet’s health. No disease-prevention or cure claims are made.

Product portfolio

Already active

12 complementary products on the market, with 4 more in development or testing. Revenue through B2B distribution, direct sales and marketplaces, supported by 260,000 B2B contacts.

12products on the market
Research, education & innovation support our shared purpose.Dogs today. A model transferable to cats & horses.
VENTURE FAIR · 05 / 20

Knowledge becomes value. Value fuels knowledge.

Science, AI, direct manufacturing and market access form a connected innovation loop.

Reinvestment closes the loop
Science & data

400,000 Harvard datasets within the contractual usage scope, 2,000 own samples and LIST cooperation under an LOI.

Expected benefits include earlier identification of developments, potentially shorter time-to-market, cost-efficient manufacturing and growing scientific know-how.

VENTURE FAIR · 07 / 20

Products today. New revenue models tomorrow.

Existing revenue and planned digital upside are not interchangeable.

Business areaRevenue modelStatus
Existing longevity productsB2B distribution, direct sales, marketplacesAlready active
New longevity productsProduct business extension; four in development / testingDevelopment / testing
Data-driven innovationBetter products, shorter development times, additional product revenuePartly in place
SaaS & managed servicesRecurring service feesBeing built
AI-powered premium featuresSubscription or usage-based feesPlanned
Digital educationPaid courses, professional content and extended servicesPlanned

Digital offerings and pricing are still in development. The financial model includes product revenue only. Foundation-related direct and indirect revenue is future upside, not modeled income.

VENTURE FAIR · 08 / 20

Our difference is the whole ecosystem.

Eight capabilities. One integrated model — with each development stage made explicit.

Being built · Biome set

Gut, skin and living environment in one concept, beyond gut-only products.

In place · usage right
Being built · LOI
Basis in place
In place · redundant
In place · contact base
Active / being built
Planned · not in model

Harvard data usage is within contractual rights, not an endorsement. LIST cooperation is under an LOI; access to 21 patents is not a claim that PawPro owns granted patents.

VENTURE FAIR · 09 / 20

A proven market. A differentiated entry.

Published industry estimates, not PawPro revenue or a guaranteed addressable market.

≈ US$2.8bn

US pet supplements market

Published estimates US$2.4–4.8bn
48%

Soft chews share

+11.2% p.a.

Powder growth

GroupExamplesFocus
Scaled US brandsZesty Paws, PetHonesty, NaturVet, NutramaxReach, Amazon and consolidation by large groups
Europe & veterinary channelYuMOVE, Nutravet, Vetoquinol, VirbacJoints and veterinary distribution
Microbiome & longevityAnimalBiome, Loyal, EpiternaMicrobiome tests and data; anti-aging drug development is distinct from supplements. AnimalBiome reports 100,000+ samples.
PawPro12 products · 360° concept · Original FormulaSales-first entry, 260,000 B2B contacts; data, AI and Foundation expansion in development

Source: public company and industry information cited in the deck. Market sizes are estimates; AnimalBiome sample count is self-reported. Supplement and drug-development models are distinct.

VENTURE FAIR · 10 / 20

Different strengths. A distinct combination.

● Available◐ Partial / in development○ Not known to us
CapabilityScaled US brandsEU & veterinaryMicrobiome & longevityPawPro
Product portfolio●●◐●12 products
360° concept (gut / skin / environment)○○◐◐Gut, skin and environment
Microbiome data at scale○○●●Harvard · ~400,000 datasets
Patents & research partners◐◐●◐21 patents · LIST LOI
AI-driven development○○○◐Basis in place · expansion planned
Shelter insights○○○◐Foundation · use from 03/2027
SaaS, education & analytics○○○◐Managed services · in development
Time to market (new)○○○●US and EU · redundant
All-in-one ecosystem○○○◐Integration from 03/2027

PawPro’s own assessment based on public information, October 2026; competitor information is not exhaustive. “Not known to us” does not establish absence. Expected advantage is the combination, not proven superiority.

VENTURE FAIR · 11 / 20

A growing network. A wider circle of care.

Pawsitiv Foundation connects shelters, owners and education — with legal independence preserved.

Network and reach grow together
PAWPRO Luxembourg

Planned platform operator: PawPro Care (27 modules), ERP/CRM, SaaS, data platform and AI as managed services.

PawPro and the Foundation are legally independent and cooperate through a managed-service agreement. Data is used only lawfully and for specified purposes. The Foundation (tax-active for one year) and US holding exist in the US; corporate integration is planned from 1 March 2027.

Animals

Long-term health and quality of life

Owners

Trust, safety and intelligent solutions

Shelters

More adoptions and digital support

Investors

Scalable, exit-ready business model

Society

Scientific progress and positive impact

VENTURE FAIR · 12 / 20

Luxembourg at the center. International by design.

Named partners, sales channels and LOI markets from the deck — not all signed partnerships.

World map showing PawPro’s named markets
Luxembourg · Planned HQ · LIST LOI

LIST, Luxinnovation, Founder Institute and Pawsitiv Foundation (US) appear in the deck network. LIST is under an LOI; do not infer all relationships are signed contracts.

Six international LOIs: Ukraine, Georgia, Azerbaijan, UAE, Brazil and one unnamed market. Further partners are available in conversation. Seeking sales, manufacturing, veterinary and laboratory partners.

VENTURE FAIR · 13 / 20

Growth of an existing business.

Three-year product-revenue base case. EBITDA before tax; digital upside excluded.

>45%

planned average contribution margin

€683k

modeled peak need · month 2

≈ €800k

target financing volume

97.5%

founder ownership · before round

Base case (€m)RevenueEBITDA before tax
Year 113.25.6
Year 240.921.1
Year 357.428.7

October 2026 deck · illustrative base case, not a forecast or investment advice. Plans depend on execution; terms are subject to negotiation.

VENTURE FAIR · 14 / 20

What is in place. What capital enables.

≈ €800k target financing

€683k modeled peak funding need, including ERP and AI, plus approximately €117k buffer. Preferably a lead investor; multiple investors, bank financing or a combination are alternatives.

  • Production and order pre-financing
  • ERP / CRM implementation: €250k
  • Existing AI expansion: €200k
  • Internationalization, new products, regulatory work and liquidity reserve

€233k is the arithmetic remainder of modeled peak need after ERP and AI, not a detailed allocation supplied by the deck.

Building blockStatusUse of funds
12 products, manufacturers & B2B baseIn placeOngoing business and production pre-financing
US distributor · 190,000 agreed unitsContractually securedOrder pre-financing; 5,000 units called off to date
Harvard data & 2,000 own samplesIn placeWithin contractual scope; no separate funds
21 patents · research with LISTBeing built · LOIFurther products and regulatory work
Health AIBasis in place · expansion€200k · analysis, information processing, innovation
ERP / CRMBeing built€250k · implementation and integration
Pawsitiv FoundationActive · transfer 03/2027US tax-active; integration planned; not in financial model
AI premium, education & SaaSPlannedPricing in development; no revenue in financial model
Internationalization & regulatoryPlannedMarket development, regulatory implementation and liquidity reserve

October 2026 deck · illustrative base case, not a forecast or investment advice. Plans depend on execution; terms are subject to negotiation.

VENTURE FAIR · 15 / 20

Around €800k. An invitation to build.

Lead investment, consortium or agreed individual amounts. Indicative terms, not a securities recommendation.

€8.0m

Indicative pre-money valuation

5.88%

Investment ÷ (€8m + investment). Example: €500k ≈ 5.9%. Assumes this investment alone; before follow-on dilution. Actual round allocation depends on agreed terms.

Exit value illustration · €500k example

Selected scenario: approximately 24% annualized over five years, before dilution. Arithmetic illustration, not a forecast.

Month 2 · −€683k low pointMonth 9 · cumulatively positive

Modeled cumulative cashflow low point: −€683k.

Positive company cashflow is not repayment to investors. Returns are via value appreciation and exit; no distributions planned. Five-year holding period for the exit illustration.

October 2026 deck · illustrative base case, not a forecast or investment advice. Plans depend on execution; terms are subject to negotiation.

VENTURE FAIR · 16 / 20

Entry terms are not a DCF result.

A transparent distinction between negotiating terms and model-based valuation.

€8.0m

Pre-money · negotiating offer

Deliberate entry terms reflecting execution risks, not an independently determined market value and not a DCF result.

“For this round we deliberately set a pre-money valuation of €8m: it reflects remaining execution risks and offers an attractive entry.”Valuation narrative · Venture Fair October 2026

October 2026 deck · illustrative base case, not a forecast or investment advice. Plans depend on execution; terms are subject to negotiation.

VENTURE FAIR · 17 / 20

Strategic acquisitions. Market context, not a promise.

TransactionBuyerPurchase priceRevenue · base yearMultiple
Zesty Paws (2021)H&H GroupUS$610mUS$73.1m (2020)≈ 8× revenue
NaturVetSwedencareUS$447.5mUS$48.4m (2020)≈ 9× revenue
PetHonesty (2021)Vestar (majority)Not disclosed in deckNot disclosed in deck—
YuMOVE (2024)Vetnique Labs (Gryphon)Not disclosed in deckNot disclosed in deck—
Zesty Paws (2021)

US$610m purchase price; ≈ 8× revenue. Values shown only where disclosed in the deck.

Source: public transaction announcements cited in the deck. These are scaled, profitable brands, not a commitment for PawPro. Revenue multiples are not comparable with the model’s 6.5× EBITDA multiple; model discount rate is 27.5%. The planned Luxembourg structure is designed for share deals.

VENTURE FAIR · 18 / 20

Execution risks. Concrete responses.

A base case is only meaningful alongside the risks that could change it.

WHAT IS BEHIND IT

Year 1: US only; 73% planned Amazon, 27% one B2B distributor.

OUR RESPONSE

Six LOIs, 12 products and additional international channels; separate contracted and planned revenue.

VENTURE FAIR · 19 / 20

The Luxembourg chapter. Step by step.

Implementation targets from November 2026 to 1 March 2027 — plans, not completed milestones.

November 2026 · TARGET

Start the Luxembourg structure

  • Incorporation & relocation
  • Three prioritized products
  • Complete financing
  • IT / ERP implementation
  • Prepare contract transfers

Luxembourg HQ is planned, not established. ISO 27001 audits are a target, not a claim of certification. Goal: an internationally scalable pet health and longevity company with economic and societal impact.

OUR NEXT CHAPTER · LUXEMBOURG

A European home.
An international vision.

Luxembourg is planned to become our headquarters — for internationalization, innovation and growth.

The holding structure is planned to begin in November 2026, with integration into the corporate structure from 1 March 2027. Our goal: an internationally scalable company for pet health and longevity, with measurable economic and societal impact.

Luxembourg·Future domain: pawpro.lu
Luxembourg
INNOVATION · INTERNATIONALIZATION · GROWTH
VENTURE FAIR · 20 / 20 · LET’S CONNECT

Let’s build the
next chapter. Together.

From an existing business to a scalable Longevity Ecosystem. Connect with our team to explore investment, research and strategic partnerships.

Growth capitalMarket accessResearchManufacturing
Katrina GraueFounder & CEO+49 155 6168 7211
Kai ErdelCFO+49 172 6941 855
Command CenterFor partners & teamVirtual LabExplore the science workspace